-
Oncology: Thalidomide, Stem-Cell Transplantation, and Leukemia Updates...Thalidomide - Update on Emerging Uses Thalidomide (Thalomid) is an antiangiogenesis agent used in the treatment of leprosy, cancer, and chronic ...
Conference Coverage, January 2001
-
Thalidomide Improves Myeloma Survival After Stem Cell TransplantationConsolidation therapy with low-dose thalidomide and prednisolone can improve survival in patients with multiple myeloma who have undergone autologous ...
News, Reuters Health Information, March 2009
-
Tandem Transplantation Effective for Untreated Multiple Myelomaautologous peripheral blood stem cell (PBSC) transplantation with thalidomide plus dexamethasone maintenance is effective against untreated multiple ...
News, Reuters Health Information, August 2009
-
Postmarketing Surveillance for Oncology DrugsThis article defines the processes involved in regulatory approval of oncology agents and discusses selected oncology drugs, labeling changes, and the role ...
Journal Article, Clin J Oncol Nurs, December 2008
-
Targeted Cancer Therapy (Oncology)and Translational Research, Phase I Program, Section Hematology and Oncology, Arizona Health Sciences CenterUpdated: Jan 3, 2010Recent Developments ...
eMedicine Clinical Reference, Updated Continually
-
Renal Cell Carcinoma (Oncology)...emedicine.medscape.com Renal Cell CarcinomaKush Sachdeva, MD, Southern Oncology and Hematology Associates, South Jersey Healthcare, Fox Chase Cancer ...
eMedicine Clinical Reference, Updated Continually
-
Kaposi Sarcoma (Oncology)SarcomaLewis J Rose, MD, Clinical Associate Professor of Medical Oncology, Thomas Jefferson University Hospital; Consulting Staff, LRCRZ ...
eMedicine Clinical Reference, Updated Continually
-
Thyroid, Follicular Carcinoma (Oncology)Surgery, Medical Center Vita, Italy; Lodovico Balducci, MD, Professor of Oncology and Medicine, University of South Florida College of Medicine; Division ...
eMedicine Clinical Reference, Updated Continually
-
Tumor Lysis Syndrome (Oncology)of Excellence in Medicine, Professor of Medicine and Chief of Hematology-Oncology, Program Director, Hematology-Oncology Fellowship, James H Quillen ...
eMedicine Clinical Reference, Updated Continually
-
Prophylactic and Therapeutic Anticoagulation for Thrombosis-Major Issues in Oncology...inpatient medical oncology population. In summary, thromboprophylaxis is likely to reduce the risk of VTE in cancer patients hospitalized for medical ...
Journal Article, Nat Clin Pract Oncol, February 2009
